363 related articles for article (PubMed ID: 24622067)
1. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
2. The expression of S100A4 in human pancreatic cancer is associated with invasion.
Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
5. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
7. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors.
Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S
Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
10. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
11. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
13. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
14. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
[TBL] [Abstract][Full Text] [Related]
15. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y
Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553
[TBL] [Abstract][Full Text] [Related]
16. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic spindle cells are an independent prognostic factor in pancreatic cancer.
Takahashi K; Hisaka T; Horiuchi H; Ishikawa H; Nakayama M; Nakashima O; Kawahara A; Kage M; Yano H; Akagi Y; Yonemoto K; Kinoshita H; Shirouzu K
Pancreas; 2015 Jul; 44(5):742-9. PubMed ID: 25931259
[TBL] [Abstract][Full Text] [Related]
19. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
